The biomarker TP53 divides patients with neoadjuvantly treated esophageal cancer into 2 subgroups with markedly different outcomes. A p53 Research Group study
Kandioler, Daniela, MD, MBA, Schoppmann, Sebastian F., MD, Zwrtek, Ronald, MD, Kappel, Sonja, PhD, Wolf, Brigitte, PhD, Mittlböck, Martina, PhD, Kührer, Irene, MD, Hejna, Michael, MD, Pluschnig, Ursula, MD, Ba-Ssalamah, Ahmed, MD, Wrba, Fritz, MD, Zacherl, Johannes, MD
Published in The Journal of thoracic and cardiovascular surgery (01.11.2014)
Published in The Journal of thoracic and cardiovascular surgery (01.11.2014)
Get full text
Journal Article
Growing clinical evidence for the interaction of the p53 genotype and response to induction chemotherapy in advanced non–small cell lung cancer
Kandioler, Daniela, MD, Stamatis, Georgios, MD, Eberhardt, Wilfried, MD, Kappel, Sonja, PhD, Zöchbauer-Müller, Sabine, MD, Kührer, Irene, MD, Mittlböck, Martina, PhD, Zwrtek, Ronald, MD, Aigner, Clemens, MD, Bichler, Christoph, JD, Tichy, Victoria, JD, Hudec, Marcus, PhD, Bachleitner, Thomas, MD, End, Adelheid, MD, Müller, Michael Rolf, MD, Roth, Erich, PhD, Klepetko, Walter, MD
Published in The Journal of thoracic and cardiovascular surgery (01.05.2008)
Published in The Journal of thoracic and cardiovascular surgery (01.05.2008)
Get full text
Journal Article